V5C-26471-42786
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 460 / IN
- Registered
- 2022-06-21
- Relationship
- Child or adolescent in my care
- Guardian
- XPD-13270-87617
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-21
Registered in v-safe
-
2022-06-22
Dose 1 — ModernaCo-administered: Hepatitis B
- 2022-06-22
- 2022-06-23
- 2022-06-24
- 2022-07-01
- 2022-07-06
- 2022-07-15
-
2022-07-21
Dose 2 — Moderna
- 2022-07-21
-
2022-07-22
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Redness · DiarrheaUnder 3 check-in
- 2022-07-24
- 2022-07-25
- 2022-09-01
-
2022-10-20
Survey response — 3 months, dose 2, under 3MedDRA: COVID-19, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID & a cold (had separately)MedDRA releases: 2024-11 · check-in free text available
- 2023-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | Hepatitis B |
| 2 | 2022-07-21 | Moderna | No |
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: COVID & a cold (had separately)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release